Veracyte VCYT
NASDAQ VCYT
$45.24 +0.95 (+2.14%)
As of: Aug 27, 2026 · 3:59 PM EDT

Veracyte (VCYT) Preferred Stock Liabilities (2012)

Veracyte (VCYT) posted quarterly Preferred Stock Liabilities of $63.4 million for Q4 2012.

Veracyte (VCYT) Preferred Stock Liabilities (2012) Analysis & Trends

Veracyte has reported Preferred Stock Liabilities for 1 years, with the latest figure at $63.4 million in Q4 2012.

  • Preferred Stock Liabilities for Q4 2012 came in at $63.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $63.4 million (changed N/A YoY), and the FY2012 annual result was $63.4 million, up 28.55% from the prior year.
  • Preferred Stock Liabilities steadied at $63.4 million in Q4 2012.
  • Over five years, Preferred Stock Liabilities peaked at $63.4 million in Q4 2012 and troughed at $63.4 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Veracyte 3.62 Bn 3.32 Bn 108.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2012 63.37 Mn